Beliefs about medication, medication adherence and seizure control among adult epilepsy patients in Kimberley, South Africa

References

• Fisher RS, van Emde BW, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470–2.10.1111/epi.2005.46.issue-4
   PubMed Web of Science ®Google Scholar
• Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.10.1111/epi.12550
   PubMed Web of Science ®Google Scholar
• Hao X-T, Kwan P. Update and overview of the International League against Epilepsy consensus definition of drug-resistant epilepsy. Eur Neurol Rev. 2011;6(1):57–9.
   Google Scholar
• Fisher RS, Shafer PO, Sirven JI. Refractory seizures. Epilepsy Foundation [Internet]. 2013 Nov [cited 2014 Oct 16]. Available from: http://www.epilepsy.com/learn/types-seizures/refractory-seizures.
   Google Scholar
• Picot MC, Baldy-Moulinier M, Daurs JP, et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia. 2008;49(7):1230–8.10.1111/epi.2008.49.issue-7
   PubMed Web of Science ®Google Scholar
• Loiseau P, Jallon P. Drug-resistant epilepsy in adults. Rev Neurol (Paris). 1995;151(5):295–306. French 6.
   PubMed Web of Science ®Google Scholar
• Berg AT, Shinnar S, Levy SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology. 2001;56(11):1445–52. 4.10.1212/WNL.56.11.1445
   PubMed Web of Science ®Google Scholar
• Jones RM, Butler JA, Thomas VA, et al. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure. 2006;15(7):504–8.10.1016/j.seizure.2006.06.003
   PubMed Web of Science ®Google Scholar
• Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study. Neurology. 2008;71(20):1572–8.10.1212/01.wnl.0000319693.10338.b9
   PubMed Web of Science ®Google Scholar
• Asawavichienjinda T, Sitthi-Amorn C, Tanyanont W. Compliance with treatment of adult epileptics in a rural district of Thailand. J Med Assoc Thai. 2003;86(1):46–51.
   PubMedGoogle Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Gatti ME, Jacobson KL, Gazmararian JA, et al. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66(7):657–64.10.2146/ajhp080064
   PubMed Web of Science ®Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.10.1097/00005650-198601000-00007
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.
   Web of Science ®Google Scholar
• Nakhutina L, Gonzalez JS, Margolis SA, et al. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav. 2011;22(3):584–6.10.1016/j.yebeh.2011.08.007
   PubMed Web of Science ®Google Scholar
• Ismail H, Wright J, Rhodes P, et al. Religious beliefs about causes and treatment of epilepsy. Br J Gen Pract. 2005;55(510):26–31.
   PubMed Web of Science ®Google Scholar
• Loiseau P, Jallon P. Drug-resistant epilepsy in adults. Rev Neurol (Paris). 1995;151(5):295–306. French.
   PubMed Web of Science ®Google Scholar
• Picot MC, Baldy-Moulinier M, Daurs JP, et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia. 2008;49(7):1230–38.10.1111/epi.2008.49.issue-7
   PubMed Web of Science ®Google Scholar
• Berg AT. Identification of pharmacoresistant epilepsy. Neurol clin. 2009;27(4):1003–13.
   PubMed Web of Science ®Google Scholar
• Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24(2):71–7.10.2337/diaclin.24.2.71
   Google Scholar
• Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia. J Clin Psychiatry. 2002;63(10):892–909.10.4088/JCP.v63n1007
   PubMed Web of Science ®Google Scholar
• Haut SR, Vouyiouklis M, Shinnar S. Stress and epilepsy: a patient perception survey. Epilepsy Behav. 2003;4(5):511–4.10.1016/S1525-5050(03)00182-3
   PubMed Web of Science ®Google Scholar
• Phatak HM, Thomas J 3rd. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;40(10):1737–42.10.1345/aph.1H153
   PubMed Web of Science ®Google Scholar